LNSR Q1 2023 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M-11.6% YoY

Gross Profit

$4M52.4% margin

Operating Income

-$4M-52.8% margin

Net Income

-$4M-51.8% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

-19.4%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$52M

Total Liabilities

$13M

Stockholders' Equity

$39M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$9M	-11.6%
Gross Profit	$4M	$5M	-7.9%
Operating Income	-$4M	-$7M	+34.7%
Net Income	-$4M	-$7M	+36.0%

Revenue Segments

Product

$6M85%

Service

$965,00015%

Geographic Segments

UNITED STATES

$4M64%

Europe

$2M23%

Asia Excluding South Korea

$708,00011%

Other Geographical Region

$104,0002%

KOREA, REPUBLIC OF

$9,0000%